A VARIETY of neoplasms has been induced by the injection of polycyclic hydrocarbons, urethane, alkylating agents and nitrosamines into newborni mice (Pietra, Spencer and Shubik, 1959; Pietra, Rappaport and Shubik. 1961 FioreDonati, Chieco-Bianchi, de Benedictis and Maiorano, 1961; Roe. Mitchley and Walters, 1963; Toth, Magee and Shubik, 1964) . The experiments to be described were designed to investigate the sensitivity of newborn mice with a viewN to using the technique for screening compounds for carcinogenic activity. A range of doses of DMBA has been tested for activity in newborn mice, and the sensitivity of the newborn to the induction of lung tumours has been coinpared witlh that of sucklings and young adults.
were inijected when less than 24 hours old.
T'he results are presented in Table I . Response was measured by lung tumour incidence, the mean number of lung tumours per surviving mouse, and the mean size of the largest tumour per tumour-bearing survivor.
A dose as small as 0625 ,Ig. DMiBA gave rise to a significantly greater incidence of lunig tumours in males, as compared with the controls (P < 0.01), but in females the difference was insignificant at doses smnaller than 2-5 ,ug. (Fig. 1) . The mean nodule count and mean size of the largest tumour increased with increasing dosages, but the tumour dose relationship was not linear . Differences in the mean number of tumours per survivor, significant at the 500 level, occurred betweeni treated and control mice with a dose of 2-5 jug. in males and 10 ,Ig. in females. There were too few controls with lung tumours to make a just comparison between the size of the largest tumours. 18 g. ± 2 g. received one injection of 15 ,tg. DMBA (Group 4), two injections of 30 ,ug. DMBA (Group 5), six injections of 30 ,tg. DMBA (Group 6) or six injections of aqueous gelatine (Group 9). Where there were two injections, one was given into each flank on the same day, and where there were six injections, three were given into each flank on three successive days. Table II shows the results in full. The effect of 15 Itg. DMBA in mice of different ages and body weights is shown in Fig. 6 and 7. The incidence of lung tumours was significantly greater in mice injected when they weighed 1P5 g. than in mice weighing 6 g. (,i-P < 0.01; -P = 0.05) or 18 g. (i-P < 001 $-P < 0.001). The differences between the 1-5 and 6 g., 1-5 and 18 g., and 6 g. and 18 g. groups with regard to mean nodule count were significant at the 1 % level for males and the 0.1 % level for females. The mean size of the largest tumour was significantly greater (P < 0(001) in mice injected (with 15 ,tg.) at 1.5g. than at 6g. or 18g.
When the dose of DMBA was related to body weight, i.e. 15 jtg. to 1-5 g. mice, 60 jug. to 6 g. mice, or 180 Itg. to 18 g. mice, the incidence of mice with pulmonary adenomas was 1000/ in all cases, both in males and females (Table IT) . Females injected neonatally had significantly higher nodule counts than female mice treated as sucklings (P < 0.001) or young adults (P = 0.01) (Fig. 8) results for males were slightly, but not significantly, different. When the means for size of the largest tumours were compared there was a significant difference (P < 0-001) between males treated as newborns and males treated as sucklings or adults, but not between females of different groups (Fig. 9) .
Malignant lung tumours occurred in mice of both sexes which received 15 ,Ig.
I)MBA at 1-5 g., 60 ,ug. at 6 g., or 180 ,ug. at 18 g. There were two Class 5 adenocarcinomas in mice treated when newborn.
Ten mice (5 i, 5 J) in Group 6, which received 180 ,ug. DMBA (90 ,tg. into each flank) developed pleomorphic or spindle cell sarcomas at one or two injection sites. In addition, two females had adenocarcinomas of mammary gland origin. One male in Group 2 had a multifocal parotid gland tumour histologically identical with those induced by the introduction of the polyoma virus into newborn mice (Stewart, 1955) .
Malignant lymphomas occurred in 1 female in Group 3, 1 female in Group 5 and 2 females and 1 male in Group 6. (1940) showed that the reaction of the lungs to carcinogens is uniform: weak carcinogens or small doses of potent carcinogens gave rise to a significantly greater incidence of tumours than seen in untreated or solventtreated control groups. When the dose of the carcinogen was increased, or a more potent carcinogen used, the multiplicity as well as the incidence of tumours increased. With 3-methylcholanthrene Shimkin (1940) found that the number of tumour-bearing mice and the average number of lung tumours per mouse were directly proportional to the dose. A later analysis of dose-response data using methylcholanthrene Shimkin and McClelland (1949) showed that the lungs of young adult strain A mice were sensitive enough a test medium to distinguish between doses of 00625, 0125 025 and 0 5 mg. The mice were killed after 8.
13 or 18 weeks. Employing the same technique, but using dibenzanthracene as the carcinogen, Heston and Schneiderman (1953) demonstrated that the lung tumour-dose relationship was linear.
By injecting newborn BALB/c mice, subcutaneously, with DMBA we have shown that lung tumour incidence, multiplicity and size increased with dose, although the tumour dose relationship was not linear. Kelly and O'Gara (1961) injected newborn non-inbred albino mice with five logarithmically spaced dose levels of dibenzanthracene or methylcholanthrene and found that the percentage of mice developing lung tumours and the number of tumours per mouse increased with dosage. The mean nodule count was the more sensitive index of response to the carcinogen.
A dose of 15 ,ug. DMBA gave rise to a significantly greater incidence, multiplicity and size of lung tumours when injected into newborn mice (1.5 g.) than into sucklings (6 g.) or young adults (18 g.). However, when the dose of DMBA was related to body weight, mice injected neonatally were hardly more sensitive than older mice. There was a significant difference between mean nodule counts in females, but not males, and between the mean size of the largest tumour in males, but not females. This result is therefore somewhat equivocal.
The results of Kelly and O'Gara are also equivocal. In their first paper (1961) the response in newborns was found to be greater than that in 3 or 6-week-old animals, whether the dose (of dibenzanthracene or methyleholanthrene) was expressed as mg. /kg. or mg. /animal. The incidence of lung tumours and the mean nodule count were recorded at 8, 16 and 24 weeks after injection. In a later experiment, however, (O'Gara and Kelly, 1963 ) the highest mean lung tuinour count at 24 weeks was in mice injected at 2 weeks of age: on a mg. 7kg. basis this mean nodule count was six times higher than that in mice injected as newborns.
Newborn mice respond to very small doses of carcinogens: to 0-625 ,ag. DMBA for the induction of pulmonary adenomas and to 0 005 ,ug. methylcholanthrene or 0 003 ,ag. dibenzanthracene for the induction of fibrosarcomas at the injection site (O'Gara, Kelly and Mantel, 1962) . But this response is not necessarily due to a special sensitivity because, on a mg./kg. basis, these doses are equivalent to doses which would be carcinogenic in adults. Except in the development of malignant lymphoma, which is probably related to the immaturity of the thymus (Pietra, Spencer and Shubik, 1959; Fiore-Donati, Chieco-Bianchi, de Benedictis and Maiorano, 1961; Rappaport and Baroni, 1962) , newborn mice appear to be hardly more sensitive than adults to carcinogenic hydrocarbons. SUMMARY 1. Groups of newborn (less than 24 hours old) BALB/c mice were injected. subcutaneously, with 40, 20, 10, 5, 2-5, 1-25 or 0 625 ,ug. DMBA in 30°aqueous gelatine. A control group received aqueous gelatine only. Lung tumour incidence. multiplicity and size increased with dose, but the tumour 'dose relationship was not linear. 0)625 jig. increased the tumour incidence above the control level in males; 2 5 jtg. did so in females.
2. 15 jag. DMBA gave rise to a significantly greater incidence of lung tumours when administered to newborn mice (body weight 1.5 g.) than to sucklings (body weight 6 g.) or young adults (body weight -18 g.). The mean nodule count was higher and size of the largest tumour greater in the neonatally-injected groups.
3. When the dose of DMBA was related to the body weight, i.e. 15 
